These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31443890)

  • 1. The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs.
    Shover CL; Abraham A; D'Aunno T; Friedmann PD; Humphreys K
    J Subst Abuse Treat; 2019 Oct; 105():44-50. PubMed ID: 31443890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.
    Mauro PM; Furr-Holden CD; Strain EC; Crum RM; Mojtabai R
    Drug Alcohol Depend; 2016 Jun; 163():108-15. PubMed ID: 27106113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Medicaid Institutions for Mental Disease Exclusion Waivers on the Availability of Substance Abuse Treatment Services and the Varying Effect by Ownership Type.
    Ge Y; Romley JA; Pacula RL
    Milbank Q; 2024 Sep; 102(3):669-691. PubMed ID: 38966909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.
    Cummings JR; Wen H; Ko M; Druss BG
    JAMA Psychiatry; 2014 Feb; 71(2):190-6. PubMed ID: 24369387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Medicaid expansion with health insurance, unmet need for medical care and substance use disorder treatment among people who inject drugs in 13 US states.
    Cooper H; Beane S; Yarbrough C; Haardörfer R; Ibragimov U; Haley D; Linton S; Beletsky L; Landes S; Lewis R; Peddireddy S; Sionean C; Cummings J;
    Addiction; 2024 Mar; 119(3):582-592. PubMed ID: 38053235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of patients with substance use disorder before and after the Affordable Care Act.
    Campbell CI; Parthasarathy S; Altschuler A; Young-Wolff KC; Satre DD
    Drug Alcohol Depend; 2018 Dec; 193():124-130. PubMed ID: 30366189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insurance Receipt and Readiness for Opportunities under the Affordable Care Act: A National Survey of Treatment Providers for Substance Use Disorders.
    Aletraris L; Edmond MB; Roman PM
    J Psychoactive Drugs; 2017; 49(2):141-150. PubMed ID: 28406363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system.
    Satre DD; Palzes VA; Young-Wolff KC; Parthasarathy S; Weisner C; Guydish J; Campbell CI
    J Subst Abuse Treat; 2020 Nov; 118():108097. PubMed ID: 32972648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between State Medicaid Eligibility Thresholds and Deaths Due to Substance Use Disorders.
    Snider JT; Duncan ME; Gore MR; Seabury S; Silverstein AR; Tebeka MG; Goldman DP
    JAMA Netw Open; 2019 Apr; 2(4):e193056. PubMed ID: 31026034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
    Johnson NL; Choi S; Herrera CN
    J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.
    Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K
    J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of perceived need and health insurance in substance use treatment: implications for the Affordable Care Act.
    Ali MM; Teich JL; Mutter R
    J Subst Abuse Treat; 2015 Jul; 54():14-20. PubMed ID: 25753655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.
    Knudsen HK; Roman PM
    J Stud Alcohol Drugs; 2014 May; 75(3):476-85. PubMed ID: 24766760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?
    Reif S; Acevedo A; Garnick DW; Fullerton CA
    Psychiatr Serv; 2017 Aug; 68(8):810-818. PubMed ID: 28412900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pennsylvania's Medical Home Initiative: Reductions in Healthcare Utilization and Cost Among Medicaid Patients with Medicaland Psychiatric Comorbidities.
    Rhodes KV; Basseyn S; Gallop R; Noll E; Rothbard A; Crits-Christoph P
    J Gen Intern Med; 2016 Nov; 31(11):1373-1381. PubMed ID: 27353455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns in Geographic Distribution of Substance Use Disorder Treatment Facilities in the US and Accepted Forms of Payment From 2010 to 2021.
    Cantor JH; DeYoreo M; Hanson R; Kofner A; Kravitz D; Salas A; Stein BD; Kapinos KA
    JAMA Netw Open; 2022 Nov; 5(11):e2241128. PubMed ID: 36367729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid Expansions and Access to Substance Abuse Treatment Services Among Limited English Proficiency Populations.
    Lee D; Dugan JA
    Med Care; 2023 Dec; 61(12):858-865. PubMed ID: 37782461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
    Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L;
    Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.